Wall Street Analysts Shake Up Ratings on Tesla, IBM, Nvidia, SpaceX & More This Tuesday
Alex Vellor
Tuesday's Wall Street analyst updates brought quite a mix, shaking up some big names across tech, retail, and healthcare sectors. JPMorgan decided to bump IBM (IBM) from neutral to overweight, citing an expected acceleration in its software business during the second half of 2026. Their deeper dive into IBM's software division seems to have sparked new optimism about growth potential.
In the tech sphere, Baird held steady on Tesla (TSLA) as an outperformer, shrugging off short-term uncertainties while spotlighting a potential merger with SpaceX sooner rather than later. Relatedly, Susquehanna initiated coverage on SpaceX itself, assigning a neutral rating with a $170 price target, hinting that patience may pay off before jumping in.
Nvidia (NVDA) and Broadcom (AVGO) earned reaffirmations from Bernstein as must-haves, with the firm emphasizing sustained demand and still undervalued stock prices. And speaking of streaming, Netflix (NFLX) remains on Bernstein's radar as an outperform, despite expected volatility and debate around its near-term challenges.
In retail, Wolfe rang some alarm bells, downgrading Home Depot (HD) to peer perform, citing erratic demand and strategic shifts that cloud question marks around earnings potential. Conversely, Wolfe put Target (TGT) in the outperform camp, pointing to renewed energy from store resets and new leadership driving a rare momentum boost.
On the healthcare front, Citi nudged American Health Care REIT higher to buy from neutral, seeing value in its relative underperformance so far this year. Meanwhile, RBC gave the nod to GE HealthCare (GEHC), forecasting growth sparked by increased R&D spending and a thickening backlog post-spin-off.
New coverage came through too, with Cantor Fitzgerald marking up Factorial Energy (FAC) as overweight, eyeing upside in the energy and battery space. Deutsche Bank initiated buys on Insulet (PODD) and DexCom (DXCM), signaling promising outlooks in diabetes device technology.
Interestingly, Jefferies kicked off coverage on FedEx Freight (FDXF) with a buy rating, drawn by margin expansion prospects and a veteran management team familiar with the playbook. Meanwhile, Deutsche Bank made a buy call on Smurfit Westrock, praising the combined high-margin prowess of its packaging operations.
On the flip side, Evercore ISI downgraded Nike (NKE) to inline from outperform, citing ongoing hurdles in its wholesale channel and a slow innovation pipeline that might stall the turnaround.
These shifts highlight a market where analysts are reevaluating sectors based on new catalysts, strategic maneuvers, and competitive positioning. The conversation around a Tesla-SpaceX tie-up adds an intriguing subplot to an already action-packed round of calls.
About The Author
Alex Vellor
Read Next in Latest Stock Market News
Sign In